Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 87.94
+1.72 (1.99%)
At close: Jul 8, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 329.01 million as of July 8, 2026. Its market cap has increased by 125.72% in one year.
Market Cap
329.01M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
87.94
Market Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 329.01M, an increase of 384.52%. That is a compound annual growth rate of 25.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 329.01M | 159.95% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ANG Lifesciences India | 439.54M |
| Vista Pharmaceuticals | 433.94M |
| Rajnish Wellness | 426.45M |
| Sandu Pharmaceuticals | 392.82M |
| JFL Life Sciences | 361.30M |
| Murae Organisor | 353.20M |
| Welcure Drugs and Pharmaceuticals | 321.34M |
| Walpar Nutritions | 316.46M |